---
title: Imaging in immunotherapy for tumor diseases
date: '2024-01-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38189933/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240109170715&v=2.18.0
source: heidelberg[Affiliation]
description: 'Immunotherapeutic agents and in particular immune checkpoint inhibitors
  (ICI) have opened up extensive new therapeutic possibilities in oncology over the
  last decade. For numerous entities these substances have improved the clinical outcome,
  sometimes as monotherapy but also in combination with cytostatic or targeted treatment.
  In routine clinical practice the type of radiological response often differs from
  what is seen under cytostatic treatment: a mixed response of individual lesions
  is ...'
disable_comments: true
---
Immunotherapeutic agents and in particular immune checkpoint inhibitors (ICI) have opened up extensive new therapeutic possibilities in oncology over the last decade. For numerous entities these substances have improved the clinical outcome, sometimes as monotherapy but also in combination with cytostatic or targeted treatment. In routine clinical practice the type of radiological response often differs from what is seen under cytostatic treatment: a mixed response of individual lesions is ...